MERIDETH LAHOUD: Open Payments
NPI 1275211070 · MATTHEWS, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$546 in 18 payments from 7 companies in 2025. Trend: 2023 $193 · 2024 $894 · 2025 $546
Food & beverage: $526Education: $20
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $285 |
| Novartis Pharmaceuticals Corporation | 3 | $71 |
| HEARTFLOW, INC. | 2 | $65 |
| CVRx, Inc. | 2 | $41 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $37 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $25 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 |
Products named: WAINUA, LEQVIO, FFRct, Barostim Neo System, Kerendia, LifeVest, JARDIANCE.
Industry payments across NC — which companies pay providers there.
